Chimeric Antigen Receptor T (CAR-T) Cells Market is a type of treatment in which a patient’s T cells, which are immune cells, are genetically modified in the laboratory to kill cancer cells. T cells are taken from a patient’s blood. T cells in the lab receive the gene for a specific receptor that binds to a specific protein on the patient’s cancer cells. Chimeric antigen receptors are a special type of receptor (CAR). CAR-T cells are mass produced in the laboratory and then injected into the patient. CAR-T therapy is used to treat certain types of blood cancers and is also being studied for use in other cancers.
Data Bridge Market Research analyzes that the Chimeric Antigen Receptor T (CAR-T) Cells Market from USD 1,965.8 Million in 2021 will reach USD 28,714.00 Million by 2029 and is expected to witness a CAGR of 39.82% over the forecast period. 2022 to 2029. Along with market insights such as market value, growth rate, market segments, geographical coverage, market players and market scenario, the market report organized by Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, price analysis, and regulatory framework.
Get Sample PDF of the Report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-chimeric-antigen-receptor-t-car-t-cells-market
Some of the Major Players operating in the Chimeric Antigen Receptor T (CAR-T) Cells Market are:
- Novartis AG (Switzerland)
- Pfizer Inc. (USA)
- Gilead Sciences, Inc. (USA)
- Autolus Therapeutics (Royaume-Uni)
- CARsgen Therapeutics Co. Ltd. (Royaume-Uni)
- Juno Therapeutics, Inc. (USA)
- Sorrento Therapeutics, Inc. (USA)
- Legend Biotech (USA)
- Calyxt Inc. (France)
- Organic Mustang (USA)
- bluebird bio, Inc. (USA)
- CELGENE CORPORATION (UNITED STATES)
- Eureka Therapeutics Inc. (USA)
- Avacta Life Sciences Ltd. (Royaume-Uni)
Market Dynamics of Chimeric Antigen Receptor T (CAR-T) Cells
Drivers
- Increased occurrences of cancer
During the forecast period 2022-2029, increasing levels of investment for the development of advanced and technical solutions and products, increasing number of cell therapy clinical studies and growth of the pharmaceutical industry will help accelerate the growth of the chimeric antigen receptor T (CAR-T) cells market. During the forecast period, the increasing use of cells for the treatment of various types of hematological and solid tumors would enhance many prospects, driving the expansion of the Chimeric Antigen Receptor T (CAR-T) Cells market ).
- Increase in the number of patients
Rising frequency of cancers, rising number of patients who have failed to respond to alternative treatments, and rising healthcare costs are all expected to drive the growth of the antigen receptor therapy market chimeric (CAR)-T. in the forecast period.
- Increase in approvals for Car-T cell therapy products
As people become more aware of this new way of treating cancer, the demand for automatic T cell therapy products is increasing. As a result, major market players are working on new products which drives the industry forward. The United States Food and Drug Administration approved Yescarta, a cell-based gene therapy, in October 2017 to treat adult patients with certain types of large B-cell lymphoma. Yescarta’s approval is a breakthrough treatment CAR-T cells for cancer patients.
- Increase R&D therapies
By 2028, the global CAR T cell processing industry is expected to reach $15 billion. CAR T therapy providers will likely benefit from increased attention to drug research and development for cancers such as lung cancer, colorectal cancer , multiple myeloma cancer, and prostate cancer. In addition to cancer, researchers are verifying the therapy’s function in various other diseases, such as HIV, autoimmune diseases, infections, and others, which will drive the market growth throughout the forecast period.
Opportunities
Additionally, as people become more aware of the efficacy, the chimeric antigen receptor (CAR) T-cell treatment market is expected to grow in the coming years. However, the potential for cytokine release syndrome (CRS) and other neurological disorders resulting from cell therapy could provide new growth prospects for the T-chimeric antigen receptor (CAR) cell therapy industry in a near future.
To get more insights into Market Analysis, browse Research Report Summary @- https://www.databridgemarketresearch.com/reports/global-chimeric-antigen-receptor-t-car-t-cells- market
Scope of the Global Chimeric Antigen Receptor T (CAR-T) Cells Market
The Chimeric Antigen Receptor T (CAR-T) Cells market is segmented on the basis of target antigen, application, and end-user. The growth among these segments will help you analyze weak growth segments in the industries and provide users with valuable market insight and market insights to help them make strategic decisions to identify major applications of the market.
Target antigen
- CD19
- CD22
- Others
Application
- Acute lymphoblastic leukemia
- Diffuse large B-cell lymphoma
- Others
Final user
- Hospitals
- Cancer research centers
- Clinics
Chimeric Antigen Receptor T (CAR-T) Cells Market Regional Analysis/Overviews
The Chimeric Antigen Receptor T (CAR-T) Cells market is analyzed and market size insights and trends are provided by country, target antigen, application and end-user as listed above. The countries covered in the Chimeric Antigen Receptor T (CAR-T) Cells market report are USA, Canada & Mexico North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey and the rest of Europe. in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel,
North America dominates the chimeric antigen receptor T cell (CAR-T) market owing to the high prevalence of cancer. Asia-Pacific is expected to grow at the highest growth rate during the forecast period of 2022 to 2029 owing to the prevalence of better healthcare infrastructure as well as growing disposable income of the people .
Browse Complete TOC at- https://www.databridgemarketresearch.com/toc/?dbmr=global-chimeric-antigen-receptor-t-car-t-cells-market
The country section of the report also provides individual market impacting factors and regulatory changes in the national market that impact current and future market trends. Data points such as upstream and downstream value chain analysis, technical trends and bearer five forces analysis, case studies are some of the indicators used to forecast the market scenario for each country. In addition, the presence and availability of global brands and the challenges they face due to significant or rare competition from local and national brands, the impact of domestic tariffs and trade routes are considered while providing a forecast analysis of national data.
Top Healthcare Report Links:
https://www.digitaljournal.com/pr/osteomyelitis-drugs-market-global-key-players-market-dynamics-future-demand-analysis-development-business-industry-technology-opportunity-and-forecasts-to-2029
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
